학술논문
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis
Document Type
Clinical report
Author
Jaccard, Arnaud; Moreau, Philippe; Leblond, Veronique; Leleu, Xavier; Benboubker, Lotfi; Hermine, Olivier; Recher, Christian; Asli, Bouchra; Jaubert, Jerome; Grosbosis, Bernard; Piette, Jean Charles; Ronco, Pierre; Quet, Fabrice; Cogne, Michel; Fermand, Jean-Paul; Lioure, Bruno; Royer, Bruno; Jardin, Fabrice; Bridoux, Frank
Source
The New England Journal of Medicine. Sept 13, 2007, Vol. 357 Issue 11, p1083, 1093 p.
Subject
Language
English
ISSN
0028-4793
Abstract
A study examines the efficiency and accuracy of high-dose melphalan in comparison with melphaln plus dexamethasone chemotherapy in immunoglobulin-light-chain (AL) amyloidosis is conducted. The high-dose melphalan is found to be a better treatment option than the melphalan plus dexamethasone.